201 related articles for article (PubMed ID: 26671484)
1. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.
Meng L; Lin J; Chen L; Wang Z; Liu M; Liu Y; Chen X; Zhu L; Chen H; Zhang J
Arch Gynecol Obstet; 2016 Jul; 294(1):29-39. PubMed ID: 26671484
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
[TBL] [Abstract][Full Text] [Related]
3. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells.
Dakhly DM; Bayoumi YA; Sharkawy M; Gad Allah SH; Hassan MA; Gouda HM; Hashem AT; Hatem DL; Ahmed MF; El-Khayat W
Int J Gynaecol Obstet; 2016 Dec; 135(3):324-327. PubMed ID: 27614789
[TBL] [Abstract][Full Text] [Related]
4. Intralipid treatment for women with reproductive failures.
Coulam CB
Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
[TBL] [Abstract][Full Text] [Related]
5. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
[TBL] [Abstract][Full Text] [Related]
6. Elevated peripheral blood natural killer cells are effectively downregulated by immunoglobulin G infusion in women with recurrent spontaneous abortions.
Kwak JY; Kwak FM; Ainbinder SW; Ruiz AM; Beer AE
Am J Reprod Immunol; 1996 Apr; 35(4):363-9. PubMed ID: 8739455
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion.
Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
J Reprod Immunol; 1996 Aug; 31(1-2):125-41. PubMed ID: 8887127
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G.
Roussev RG; Ng SC; Coulam CB
Am J Reprod Immunol; 2007 Apr; 57(4):262-9. PubMed ID: 17362387
[TBL] [Abstract][Full Text] [Related]
9. Changes and clinical significance of peripheral blood helper T lymphocyte and natural killer (NK) cells in unexplained recurrent spontaneous abortion (URSA) patients after abortion and successful pregnancy .
Zhu LY; Chen X; Xu ZZ; Xu L; Mao T; Zhang H
Clin Exp Obstet Gynecol; 2015; 42(1):62-6. PubMed ID: 25864284
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of intravenous immunoglobulin therapy in treating unexplained recurrent spontaneous abortion and its effect on the level of serum soluble human leucocyte antigen G].
Sun XG; Liu XY; Zhu R; Fan GS; Zhang Y; Chen FL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Oct; 32(5):483-7. PubMed ID: 21050549
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion.
Ruiz JE; Kwak JY; Baum L; Gilman-Sachs A; Beaman KD; Kim YB; Beer AE
Am J Reprod Immunol; 1996 Apr; 35(4):370-5. PubMed ID: 8739456
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Immunoglobulin Suppresses Abortion Relates to an Increase in the CD44bright NK Subset in Recurrent Pregnancy Loss Model Mice.
Tanaka J; Kitashoji A; Fukunaga Y; Kashihara J; Nakano A; Kamizono A
Biol Reprod; 2016 Aug; 95(2):37. PubMed ID: 27335067
[TBL] [Abstract][Full Text] [Related]
13. Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy.
van den Heuvel MJ; Peralta CG; Hatta K; Han VK; Clark DA
Am J Reprod Immunol; 2007 Nov; 58(5):447-59. PubMed ID: 17922698
[TBL] [Abstract][Full Text] [Related]
14. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer.
Check JH; Check DL
Clin Exp Obstet Gynecol; 2016; 43(1):14-5. PubMed ID: 27048011
[TBL] [Abstract][Full Text] [Related]
15. High doses of intravenous immunoglobulin stimulate regulatory T cell and suppress natural killer cell in women with recurrent pregnancy loss.
Yamada H; Deguchi M; Saito S; Takeshita T; Mitsui M; Saito T; Nagamatsu T; Takakuwa K; Nakatsuka M; Yoneda S; Egashira K; Tachibana M; Matsubara K; Honda R; Fukui A; Tanaka K; Sengoku K; Endo T; Yata H
J Reprod Immunol; 2023 Aug; 158():103977. PubMed ID: 37354783
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the risk of unexplained recurrent spontaneous abortion based on the proportion and correlation of NK cells and T cells in peripheral blood.
Du M; Li Y; Gu H; Gao M; Xu H; Zhong W; Liu X; Zhong X
Technol Health Care; 2023; 31(S1):97-109. PubMed ID: 37038785
[TBL] [Abstract][Full Text] [Related]
17. Does immunotherapy for treatment of reproductive failure enhance live births?
Coulam CB; Acacio B
Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
[TBL] [Abstract][Full Text] [Related]
18. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double-blinded, placebo-controlled trial.
Stephenson MD; Dreher K; Houlihan E; Wu V
Am J Reprod Immunol; 1998 Feb; 39(2):82-8. PubMed ID: 9506206
[TBL] [Abstract][Full Text] [Related]
19. The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.
Singh N; Davis AA; Kumar S; Kriplani A
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():45-51. PubMed ID: 31228675
[TBL] [Abstract][Full Text] [Related]
20. NK cell frequency and cytotoxicity in correlation to pregnancy outcome and response to IVIG therapy among women with recurrent pregnancy loss.
Ahmadi M; Ghaebi M; Abdolmohammadi-Vahid S; Abbaspour-Aghdam S; Hamdi K; Abdollahi-Fard S; Danaii S; Mosapour P; Koushaeian L; Dolati S; Rikhtegar R; Oskouei FD; Aghebati-Maleki L; Nouri M; Yousefi M
J Cell Physiol; 2019 Jun; 234(6):9428-9437. PubMed ID: 30317625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
